Skip to main content
Equibles
PRCT logo

PRCT · PROCEPT BioRobotics Corp

Track PRCT — free

Use PRCT with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about PRCT

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$21.65 -0.30 (-1.37%) At close · Aug 14
Market Cap
$1.24B
Shares
57.27M

PROCEPT BioRobotics Corp Earnings Call Transcripts

Every quarterly earnings call for PROCEPT BioRobotics Corp (PRCT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲134.8% $20.35M −$22.61M '22 Q3 22-11-03 ▲134.6% $23.78M −$28.17M '22 Q4 23-02-28 ▲71.9% $24.40M −$28.48M '23 Q1 23-04-27 ▲98.3% $33.10M −$25.29M '23 Q2 23-07-27 ▲72.5% $35.10M −$24.62M '23 Q3 23-11-01 ▲83.3% $43.58M −$27.51M '23 Q4 24-02-27 ▲82.5% $44.54M −$25.96M '24 Q1 24-05-01 ▲61.2% $53.35M −$25.63M '24 Q2 24-08-01 ▲66.3% $58.37M −$20.97M '24 Q3 24-10-28 ▲56.6% $68.24M −$18.86M '24 Q4 25-02-25 ▲55.3% $69.16M −$24.74M '25 Q1 25-04-24 ▲48.4% $79.18M −$19.58M '25 Q2 25-08-06 ▲42.8% $83.33M −$21.41M '25 Q3 25-11-04 ▲11.9% $76.38M −$29.85M '25 Q4 26-02-25 ▲20.2% $83.13M −$31.64M '26 Q1 26-04-29 LATEST ▲19.3% $94.50M −$26.86M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
Q2 2026 Procept BioRobotics Earnings Conference Call
Positive tone Procedure growth shortfall in legacy AquaBeam accounts Guidance and path to profitability Hydros robotic system rollout
Revenue
$94.50M
▲ 19.3% YoY
Diluted EPS
$-0.47
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-02
46th Annual William Blair Growth Stock Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-04-29
PROCEPT BioRobotics Corp Q1 FY2026 Earnings Call
Confident tone Revenue and procedure growth Pricing discipline and ASP Commercial realignment and launch team
Revenue
$83.13M
▲ 20.2% YoY
Diluted EPS
$-0.56
Gross margin
64.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-25
PROCEPT BioRobotics Corp Q4 FY2025 Earnings Call
Positive tone Capital system placements Procedure growth and utilization Profitability path and operating expenses
Revenue
$76.38M*
▲ 11.9% YoY
Gross margin
60.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-04
PROCEPT BioRobotics Corp Q3 FY2025 Earnings Call
Positive tone Procedure utilization / new account launches U.S. capital systems / HYDROS placements BPH market opportunity / therapy awareness
Revenue
$83.33M
▲ 42.8% YoY
Diluted EPS
$-0.38
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
PROCEPT BioRobotics Corp Q2 FY2025 Earnings Call
Confident tone HYDROS platform launch Gross margin and path to profitability WATER IV trial and prostate cancer
Revenue
$79.18M
▲ 48.4% YoY
Diluted EPS
$-0.35
Gross margin
65.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-04-24
PROCEPT BioRobotics Corp Q1 FY2025 Earnings Call
Confident tone Commercial execution and account launches Revenue and unit growth Capital equipment sales cycle and pipeline
Revenue
$69.16M
▲ 55.3% YoY
Diluted EPS
$-0.45
Gross margin
63.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-25
PROCEPT BioRobotics Corp Q4 FY2024 Earnings Call
Confident tone HYDROS Robotic System Launch BPH Market Share and Standard of Care Revenue Growth and Procedures
Revenue
$68.24M*
▲ 56.6% YoY
Gross margin
64.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-28
PROCEPT BioRobotics Corp Q3 FY2024 Earnings Call
Confident tone HYDROS Robotic System Launch Prostate Cancer Clinical Study / WATER IV PCa Q4 2024 Guidance and System Sales Outlook
Revenue
$58.37M
▲ 66.3% YoY
Diluted EPS
$-0.40
Gross margin
63.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
PROCEPT BioRobotics Corp Q2 FY2024 Earnings Call
Confident tone Revenue growth and U.S. system sales Prostate cancer expansion and clinical studies Gross margin and operating leverage
Revenue
$53.35M
▲ 61.2% YoY
Diluted EPS
$-0.50
Gross margin
59.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
PROCEPT BioRobotics Corp Q1 FY2024 Earnings Call
Confident tone Revenue Growth and Financial Performance U.S. Installed Base and Hospital Adoption Prostate Cancer Opportunity and AUA Conference
Revenue
$44.54M
▲ 82.5% YoY
Diluted EPS
$-0.51
Gross margin
56.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-27
PROCEPT BioRobotics Corp Q4 FY2023 Earnings Call
Confident tone Revenue Growth and Utilization BPH Standard of Care Strategy IDN and Reimbursement
Revenue
$43.58M*
▲ 83.3% YoY
Gross margin
48.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
PROCEPT BioRobotics Corp Q3 FY2023 Earnings Call
Revenue
$35.10M
▲ 72.5% YoY
Diluted EPS
$-0.51
Gross margin
53.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
PROCEPT BioRobotics Corp Q2 FY2023 Earnings Call
Revenue
$33.10M
▲ 98.3% YoY
Diluted EPS
$-0.56
Gross margin
55.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-04-27
PROCEPT BioRobotics Corp Q1 FY2023 Earnings Call
Revenue
$24.40M
▲ 71.9% YoY
Diluted EPS
$-0.63
Gross margin
51.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
PROCEPT BioRobotics Corp Q4 FY2022 Earnings Call
Revenue
$23.78M*
▲ 134.6% YoY
Gross margin
44.9%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
PROCEPT BioRobotics Corp Q3 FY2022 Earnings Call
Revenue
$20.35M
▲ 134.8% YoY
Diluted EPS
$-0.51
Gross margin
50.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
PROCEPT BioRobotics Corp Q2 FY2022 Earnings Call
Revenue
$16.69M
▲ 96.9% YoY
Diluted EPS
$-0.43
Gross margin
50.8%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
PROCEPT BioRobotics Corp Q1 FY2022 Earnings Call
Revenue
$14.20M
▲ 97.4% YoY
Diluted EPS
$-0.39
Gross margin
54.2%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-01-11
PROCEPT BioRobotics Corp Q4 FY2021 Earnings Call
Revenue
$10.14M*
Gross margin
44.5%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
PROCEPT BioRobotics Corp Q3 FY2021 Earnings Call
Revenue
$8.67M
▲ 311.4% YoY
Diluted EPS
$-1.22
Gross margin
48.9%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–21 of 21 earnings calls
Key facts CIK 1588978 CUSIP 74276L105 13F (30d) 250 filings 244 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)